Document is current

Any future updates will be listed below

Real-World Experience and Laboratory Monitoring of Dupilumab in Patients with Moderate to Severe Atopic Dermatitis in a Tertiary Centre

Crossref DOI link: https://doi.org/10.1007/s13555-020-00469-6

Published Online: 2020-12-14

Published Print: 2021-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark